Treatment News : Even Very Low Viral Loads Can Lead to Treatment Failure

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » September 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

September 9, 2013

Even Very Low Viral Loads Can Lead to Treatment Failure

HIV-positive people on antiretrovirals (ARVs) who have a persistently detectable viral load are at an increased risk for treatment failure, even when the levels are as low as 50 to 199, aidsmap reports. Publishing their findings in the online edition of Clinical Infectious Diseases, Canadian researchers studied 1,357 people treated for HIV in Montreal, beginning in 1999. The participants were required to take ARVs for 12 months; the follow-up period extended as long as 12 years.

U.S. treatment guidelines state that there is no evidence that viral loads below 200 increase the risk for treatment failure, which is also known as virologic failure. Contrasting this, the study authors state that even detectable viral loads in this low range (a viral load is detectable at 50 or above) should prompt clinicians to “act aggressively,” addressing adherence issues, drug dosage, drug interactions, genotype testing and conducting other forms of closer monitoring.

Among the study participants who maintained an undetectable viral load, only 7 percent experienced treatment failure, defined as a viral load rising above 1,000. Out of those who had a persistent viral load between 50 and 199, 23 percent failed treatment. Those with a viral load between 200 and 499 failed at a rate of 24 percent, and those with a viral load between 500 and 999 failed at a rate of 59 percent.

After controlling for various factors, the researchers concluded that having a persistent viral load between 50 and 199 or between 200 and 499 slightly more than doubled the risk of treatment failure; and those with a persistent viral load between 500 and 999 have a nearly fivefold increased risk.

To read the aidsmap story, click here.

To read the study abstract, click here.

Search: HIV, treatment failure, virologic failure, Clinical Infectious Diseases, low viral load, persistently detectable viral load.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


         


[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Is youth leadership important in the HIV/AIDS fight?
Yes
No

Survey
Smoke Signals

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.